There are 2867 resources available
1521P - Comprehensive genomic profiling (CGP) of epithelioid hemangioendothelioma (EHE) and liver angiosarcomas (LAS)
Presenter: Aditya Shreenivas
Session: Poster session 11
1108P - Outcomes when stage IV non-small cell lung cancer (NSCLC-4) patients (pts) harboring oncogenic drivers (OD) are treated initially without tyrosine kinase inhibitors (TKI)
Presenter: Rushir Choksi
Session: Poster session 15
836P - Outcome of PD-1 inhibitor therapy of advanced melanoma patients according to demographic factors in a real-world setting across Europe
Presenter: Michael Weichenthal
Session: Poster session 03
1522P - Is it safe to discontinue the tyrosine kinase inhibitors in advanced sarcoma following a favorable tumor response to antiangiogenics therapy?
Presenter: Qiyuan Bao
Session: Poster session 11
1109P - Amivantamab vs real-world (RW) therapy in Japanese patients with advanced non-small cell lung cancer (aNSCLC) epidermal growth factor receptor (EGFR) exon-20 insertion mutation (E20i)
Presenter: Tae Min Kim
Session: Poster session 15
837P - Real-world evidence of encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma in Spain (GEM 2002 - BECARE)
Presenter: Ainara Soria Rivas
Session: Poster session 03
1523P - Incidence and geographic distribution of bone and soft tissue sarcoma in Japan using a nationwide population-based analysis: 69,734 cases
Presenter: Tatsunori Shimoi
Session: Poster session 11
1110P - Clinical outcomes for EGFR/HER2 exon 20 insertion-mutated NSCLC
Presenter: Kelly Li
Session: Poster session 15
838P - Patterns of response/progressive disease (PD) and management following PD with anti-PD-1 (PD1) in patients (pts) with advanced cutaneous squamous cell carcinoma (cSCC)
Presenter: Jeremy Mo
Session: Poster session 03
1524P - Epidemiology and demography of gynecological sarcoma: Results of the prospective intergroup registry for gynecological sarcoma REGSA (NOGGO RU1)
Presenter: Eva Roser
Session: Poster session 11